PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation

Recruited vs. nonrecruited molecular signatures of brown, “brite,” and white adipose tissues

(2011) Tomas B. Waldén et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

The role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation

(2011) Harini Sampath et al.   Annals of the New York Academy of Sciences

A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: Design and synthesis of benzylpyrazole acylsulfonamides

(2011) Kentaro Rikimaru et al.   BIOORGANIC & MEDICINAL CHEMISTRY

A Prospective Study of the Associations Between Treated Diabetes and Cancer Outcomes

(2011) H.-C. Yeh et al.   DIABETES CARE

PPARγ: A molecular link between systemic metabolic disease and benign prostate hyperplasia

(2011) Ming Jiang et al.   DIFFERENTIATION

The Correlation Between Metabolic Syndrome and Prostatic Diseases

(2011) Cosimo De Nunzio et al.   EUROPEAN UROLOGY

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

(2011) Goodarz Danaei et al.   LANCET

Urological aspects of the metabolic syndrome

(2011) Jan Hammarsten et al.   Nature Reviews Urology

Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats

(2010) Gene Hsiao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Autophagy in nuclear receptor PPARγ-deficient mouse prostatic carcinogenesis

(2010) Ming Jiang et al.   Autophagy

Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia

(2010) Ajit Vikram et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other Causes

(2010) B. Grundmark et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Perspectives on Tissue Interactions in Development and Disease

(2010) D. Strand et al.   CURRENT MOLECULAR MEDICINE

Metabolic alterations and targeted therapies in prostate cancer

(2010) Richard Flavin et al.   JOURNAL OF PATHOLOGY

Abrogation of De novo Lipogenesis by Stearoyl-CoA Desaturase 1 Inhibition Interferes with Oncogenic Signaling and Blocks Prostate Cancer Progression in Mice

(2010) V. Fritz et al.   MOLECULAR CANCER THERAPEUTICS

Peroxisome proliferator-activated receptor translational research and clinical experience

(2009) Wayman Wendell Cheatham   AMERICAN JOURNAL OF CLINICAL NUTRITION

Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice

(2009) Makoto Miyazaki et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms

(2009) Jose Antonio Chavez et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Disruption of PPARγ signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy

(2009) M Jiang et al.   CELL DEATH AND DIFFERENTIATION

Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization

(2009) D. D. Sears et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Increased cell proliferation and contractility of prostate in insulin resistant rats: Linking hyperinsulinemia with benign prostate hyperplasia

(2009) A. Vikram et al.   PROSTATE